NEWS

January 9, 2020

HealthCare Royalty Partners Raises $1.8 Billion

October 25, 2019

GSK receives prestigious Prix Galien USA award for SHINGRIX

September 16, 2019

Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million

March 6, 2019

Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA™ for $30 Million Gross Proceeds

March 1, 2019

Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management

February 27, 2019

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

January 7, 2019

Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners

November 5, 2018

Grünenthal Acquires Global Rights for Qutenza^®

November 2, 2018

U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)

October 23, 2018

Gary A. Lyons Joins HealthCare Royalty Partners Senior Advisor Board